![]() |
Name
Cash Bids
Market Data
News
Ag Commentary
Weather
Resources
|
Is Travelers Companies Stock Outperforming the S&P 500?![]() New York-based The Travelers Companies, Inc. (TRV) provides a range of commercial and personal property and casualty insurance products and services to businesses, government units, associations, and individuals in the United States and internationally. With a market cap of $61.8 billion, the company operates through three segments: Business Insurance, Bond & Specialty Insurance, and Personal Insurance. Companies worth $10 billion or more are generally described as "large-cap stocks." TRV fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the property and casualty insurance industry. With over 34,00 employees, the company offers its insurance and surety products and services all across the globe. TRV is down 1.5% from its 52-week high of $277.83, achieved on recently Jun. 3. Shares of TRV have grown 6.9% over the three months, compared to the S&P 500 Index’s ($SPX) 4.6% rise. ![]() Over the long term, TRV is up 13.6% on a YTD basis and 30.5% over the past 52 weeks. By contrast, $SPX has gained 2% in 2025 and 12.1% over the past year, underperforming the stock. To confirm its bullish trend, TRV has been trading mostly above its 200-day moving average for the past year and above its 50-day moving average since late April. ![]() TRV shares surged 1.1% following the release of its Q1 earnings on Apr. 16. The company reported a 5% year-over-year increase for its revenue, which came in at $11.8 billion. Moreover, its adjusted earnings amounted to $1.91 for the quarter and surpassed the consensus estimates by a whopping 198.4%. Its peer, The Progressive Corporation (PGR), has slightly outperformed the stock, with its shares surging 16.5% in 2025 and 31% over the past year. Analysts remain moderately optimistic about its prospects. The stock has a consensus rating of “Moderate Buy” from the 24 analysts in coverage, and the mean price target of $285.24 suggests a premium of 4.2% to its current levels. On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here. |
|